Lupin informs about press release

30 Apr 2020 Evaluate

Lupin has informed that it has enclosed a Press Release on 30th April 2020 as regards receipt of Establishment Inspection Report from the US FDA for the Company’s Pithampur Unit-1, India facility. Inspection for the said facility was conducted by the US FDA between February 3, 2020 and February 11, 2020 and concluded with two observations.

The above information is a part of company’s filings submitted to BSE. 

Lupin Share Price

2138.65 -12.40 (-0.58%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.20
Dr. Reddys Lab 1182.75
Cipla 1325.85
Zydus Lifesciences 878.80
Lupin 2138.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×